MENU
JBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jade Biosciences (JBIO) Ownership - Who owns Jade Biosciences?

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
689.14M
P/E Ratio
N/A
Total Cash
198.91M
Projected Growth
N/A
Total Debt
747K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

JBIO
Capitalization
689M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
199M
Total Cash/Share
4.32
Total Debt
747K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
179M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
9.01
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
381M
Shares Outstanding - Current
46M
Total Liabilities
23.1M
Total Volume MTD
N/A
Value
1
Gain YTD
460.000
View a ticker or compare two or three
JBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details